Management of hepatitis C virus (HCV) infection in drug substitution programs

Witteck, Andrea; Schmid, Patrick; Hensel-Koch, Katharina; Thurnheer, Maria C; Bruggmann, Philip; Vernazza, Pietro; Swiss Hepatitis C and HIV Cohort Studies, (2011). Management of hepatitis C virus (HCV) infection in drug substitution programs. Swiss medical weekly, 141, w13193. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13193

Full text not available from this repository.

In Switzerland, intravenous drug use (IDU) accounts for 80% of newly acquired hepatitis C virus (HCV) infections. Early HCV treatment has the potential to interrupt the transmission chain and reduce morbidity/mortality due to decompensated liver cirrhosis and hepatocellular carcinoma. Nevertheless, patients in drug substitution programs are often insufficiently screened and treated.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Thurnheer Zürcher, Maria Christine

ISSN:

1424-7860

Publisher:

EMH Schweizerischer Ärzteverlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:24

Last Modified:

05 Dec 2022 14:07

Publisher DOI:

10.4414/smw.2011.13193

PubMed ID:

21623473

Web of Science ID:

000291025600001

URI:

https://boris.unibe.ch/id/eprint/8276 (FactScience: 213793)

Actions (login required)

Edit item Edit item
Provide Feedback